Company intelligence / Profile preview

WizeCare

Hartford, Connecticut, United Stateswizecare.com ↗

Ownership: Private
Development stage: Other

Overview

WizeCare’s AI-powered telerehabilitation platform has demonstrated clinical efficacy in two published trials, showing significant improvements in pain reduction, functional improvement, and recovery time. The solution is deployed commercially with leading Israeli HMOs and expanding internationally.

Therapeutic areas: Rheumatology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Essen Health Care (US-based partnership for value-based care)Leading Israeli HMOs (multi-year commercial agreements)

Beyond the preview

Go deeper on WizeCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WizeCare.

Explore the full profile